Literature DB >> 29050790

Effects of a nicotinic agonist on the Brief Psychiatric Rating Scale five-factor subscale model in schizophrenia.

Alan S Lewis1, Ann Olincy2, Robert W Buchanan3, William R Kem4, Marina R Picciotto5, Robert Freedman2.   

Abstract

Entities:  

Keywords:  Affect; Alpha-7 nicotinic acetylcholine receptor; Brief Psychiatric Rating Scale; Clinical trial; DMXB-A; Schizophrenia

Mesh：

Substances：

Year:  2017        PMID： 29050790      PMCID： PMC6476180          DOI： 10.1016/j.schres.2017.10.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  10 in total

1.  Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.

Authors:  Ann Olincy; Josette G Harris; Lynn L Johnson; Vicki Pender; Susan Kongs; Diana Allensworth; Jamey Ellis; Gary O Zerbe; Sherry Leonard; Karen E Stevens; James O Stevens; Laura Martin; Lawrence E Adler; Ferenc Soti; William R Kem; Robert Freedman
Journal:  Arch Gen Psychiatry       Date:  2006-06

2.  Multiple Nicotinic Acetylcholine Receptor Subtypes in the Mouse Amygdala Regulate Affective Behaviors and Response to Social Stress.

Authors:  Yann S Mineur; Gianna M Fote; Sam Blakeman; Emma L M Cahuzac; Sylvia A Newbold; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2015-10-16       Impact factor: 7.853

Review 3.  α7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia.

Authors:  Robert Freedman
Journal:  Annu Rev Med       Date:  2013-10-09       Impact factor: 13.739

Review 4.  Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies.

Authors:  Alan S Lewis; Gerrit I van Schalkwyk; Michael H Bloch
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-01-05       Impact factor: 5.067

5.  Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.

Authors:  Monica M Marcus; Carl Björkholm; Anna Malmerfelt; Annie Möller; Ninni Påhlsson; Åsa Konradsson-Geuken; Kristin Feltmann; Kent Jardemark; Björn Schilström; Torgny H Svensson
Journal:  Eur Neuropsychopharmacol       Date:  2016-07-26       Impact factor: 4.600

6.  Meta-analysis of the brief psychiatric rating scale factor structure.

Authors:  Alan Shafer
Journal:  Psychol Assess       Date:  2005-09

7.  Initial phase 2 trial of a nicotinic agonist in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Robert W Buchanan; Josette G Harris; James M Gold; Lynn Johnson; Diana Allensworth; Alejandrina Guzman-Bonilla; Bettye Clement; M Patricia Ball; Jay Kutnick; Vicki Pender; Laura F Martin; Karen E Stevens; Brandie D Wagner; Gary O Zerbe; Ferenc Soti; William R Kem
Journal:  Am J Psychiatry       Date:  2008-04-01       Impact factor: 18.112

8.  A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.

Authors:  Daniel Umbricht; Richard S E Keefe; Stephen Murray; David A Lowe; Richard Porter; George Garibaldi; Luca Santarelli
Journal:  Neuropsychopharmacology       Date:  2014-01-27       Impact factor: 7.853

9.  Modulation of aggressive behavior in mice by nicotinic receptor subtypes.

Authors:  Alan S Lewis; Yann S Mineur; Philip H Smith; Emma L M Cahuzac; Marina R Picciotto
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

10.  Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia.

Authors:  Richard S E Keefe; Herbert A Meltzer; Nancy Dgetluck; Maria Gawryl; Gerhard Koenig; Hans J Moebius; Ilise Lombardo; Dana C Hilt
Journal:  Neuropsychopharmacology       Date:  2015-06-19       Impact factor: 7.853
  10 in total
  2 in total

Review 1.  Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies.

Authors:  Alan S Lewis; Marina R Picciotto
Journal:  Neuropharmacology       Date:  2019-12-26       Impact factor: 5.250

Review 2.  Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications.

Authors:  Igor Kasheverov; Denis Kudryavtsev; Irina Shelukhina; Georgy Nikolaev; Yuri Utkin; Victor Tsetlin
Journal:  Biomolecules       Date:  2022-01-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.